Sunday, February 9, 2025

Medtronic’s Deep Brain Stimulation System for Enhanced Neurological Disorder Treatment Approved by FDA

Similar articles

Medtronic plc, a global leader in healthcare technology, announced a major advancement in the field of neurostimulation with the U.S. Food and Drug Administration (FDA) approval of its Perceptâ„¢ RC Deep Brain Stimulation (DBS) system. This latest innovation in the Medtronic Perceptâ„¢ family, including the Perceptâ„¢ PC neurostimulator, BrainSenseâ„¢ technology, and SenSightâ„¢ directional leads, represents a significant leap in the treatment of movement disorders and epilepsy, which affect millions of people in the U.S.

Key Features and Impact of Medtronic Perceptâ„¢ RC

Subscribe Weekly Market Access News

* indicates required
  1. Innovative Technology: The Perceptâ„¢ RC system is the only sensing-enabled Deep Brain Stimulation system on the market, allowing physicians to personalize treatment for patients with movement disorders such as Parkinson’s disease, essential tremor, dystonia, and epilepsy.
  2. Smallest and Thinnest Neurostimulator: Perceptâ„¢ RC is the smallest and thinnest dual-channel neurostimulator available for Deep Brain Stimulation. It’s equipped with BrainSenseâ„¢ technology that captures and records brain signals, providing insights to adapt therapy to a patient’s evolving needs.
  3. Long Battery Life and Rapid Recharging: The Perceptâ„¢ RC battery offers at least 15 years of service life with consistent and fast recharge performance, significantly longer than other rechargeable devices. Patients can rapidly recharge from 10% to 90% in less than an hour.
  4. Personalized Therapy and Sensing Capability: The sensing capability of Perceptâ„¢ RC allows physicians to tune stimulation delivery to brain activity, potentially personalizing therapy for Parkinson’s disease and other conditions in the future.
  5. MRI Compatibility: Medtronic was the first in the U.S. to offer full-body MR Conditional Deep Brain Stimulation systems, allowing patients to have safe MRI scans anywhere on the body under specific conditions.
  6. Future Software Updates: The Perceptâ„¢ neurostimulators are engineered for future software updates designed for the Perceptâ„¢ platform without needing a neurostimulator device exchange.
  7. Clinical Insights Outside the Clinic: The rechargeable DBS therapy option with sensing technology enables physicians to track a patient’s response to DBS and medications, providing valuable data for personalizing and optimizing patient therapy.
  8. Global Availability and Impact: Since 1987, Medtronic’s DBS therapy has served over 180,000 patients in more than 70 countries. Perceptâ„¢ RC is available immediately in the U.S., Europe, and Japan.
  9. Expert Endorsement: Experts like Dr. Eleni Okeanis Vaou, a deep brain stimulation specialist, highlight the device’s ability to provide insights into patients’ symptoms and capture data even when they’re outside the clinic, aiding in the personalization of therapy.
  10. Impact on Patients with Movement Disorders and Epilepsy: This technology offers hope and improved quality of life for the 11 million people in the U.S. living with movement disorders and the approximately 3.4 million with epilepsy.

Deep Brain Stimulation

Medtronic’s Deep Brain Stimulation System: A Revolutionary Leap in Neurological Disorder Treatment

In conclusion, the FDA approval of Medtronic’s Perceptâ„¢ RC DBS system marks a significant advancement in the treatment of neurological disorders. By enabling personalized therapy through advanced sensing capabilities and offering a long battery life with rapid recharging, Perceptâ„¢ RC stands out as a transformative solution for patients with movement disorders and epilepsy. Its innovative design, combined with MRI compatibility and potential for future updates, positions it as a leading technology in neurostimulation, with the promise of improving the lives of patients across the globe.

 

Resource: Medtronic, January 09, 2024


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article